Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
about
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersVitamin D and Immune Response: Implications for Prostate Cancer in African AmericansObesity and cancer: mechanistic insights from transdisciplinary studiesImmune Infiltration and Prostate CancerAlleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory DrugsBiases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials.Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.Preventing aggressive prostate cancer with proven cardiovascular disease preventive methodsThe association between regular use of aspirin and the prevalence of prostate cancer: Results from the National Health Interview SurveyThe origin of prostate metastases: emerging insights.Cancer Cell-Autonomous Parainflammation Mimics Immune Cell Infiltration.Telomeres and telomerase in prostate cancer development and therapy.Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.Warfarin use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections.Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.Aspirin and prostate cancer preventionAspirin Use Reduces the Risk of Aggressive Prostate Cancer and Disease Recurrence in African-American Men.WNT signalling in prostate cancer.Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS- Mutant Cancers.A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly.Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database.Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.Drug Repositioning for Effective Prostate Cancer Treatment.Intake of Non-steroidal Anti-inflammatory Drugs and the Risk of Prostate Cancer: A Meta-Analysis
P2860
Q26739665-A6824914-99B2-4523-8F3A-02AA5BC77295Q26768536-544CAD71-AEB3-44C3-915D-B0235F8051C9Q26786829-EF130758-BD4F-4648-91CE-C829C7F88B35Q26798412-2979FA56-4E96-49F8-A880-3EB144156089Q30234292-E919511F-6A69-411D-AB60-DDAEFED6C656Q33756403-FA1A5C83-3B07-4715-AF6F-B520E9B05A4CQ35653603-BB01F57E-5E93-44DD-B72F-679856CB32B0Q36748541-B84AE976-ABFC-41F1-8F3D-2F85C94B4698Q37205121-A789FFF2-DA2A-4E64-B7AD-2380D105D6A3Q38585564-967E78EC-2744-4E76-9A79-B53EBA8AAAF7Q38699338-DCE72023-8DD2-4B9F-AFD1-49109A2E312AQ39413214-A3636B56-A5A4-4671-90B9-D9CECF36F2C2Q39438805-D829855B-FE3D-42C0-8442-AE587F57B459Q39509938-C6FB4F4E-11F6-44EC-84E0-37BF46CE82CCQ40501806-2EAEE66B-D4D5-4B34-AD55-17677887566BQ40756146-1EA83A9F-584F-47F9-9699-D958380F6CADQ40880405-ECC16194-27A5-4453-8095-4C4F58883745Q42373340-7CBEDBD0-E406-4A60-B380-12FD6FCA2866Q42430928-EF6ED7C2-D6B1-4B28-A4B0-BC7C8441A81BQ46176546-D66CC1A4-A354-46AD-91BB-FF3661194821Q47818549-3433E62B-D775-4928-BD2B-17332E2F05ACQ48583910-2E5FCAC2-9A9E-4000-8694-D4844A26A115Q49385576-6B19A2CF-0958-4AD4-BA39-869700AFBDCCQ50082353-A7808BE0-88C8-4D97-8BAE-6F0C9A2B51DAQ51244733-EF106360-8167-47E4-87D7-589BE0B556B3Q52584079-F0342DB1-19AA-4C72-9F6C-89F7417C372BQ52743780-A2AAEF1E-4173-499F-B027-D421126C70E0Q55254671-1A42FDDE-4277-406C-8380-B72B6E54ABF5Q58573444-90647654-87F5-4D28-9496-5DC8EF13B9A3
P2860
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
@ast
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
@en
type
label
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
@ast
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
@en
prefLabel
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
@ast
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
@en
P2093
P2860
P1476
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
@en
P2093
Adriana C Vidal
Gerald L Andriole
Lauren E Howard
Ramiro Castro-Santamaria
Stephen J Freedland
P2860
P304
P356
10.1158/1078-0432.CCR-14-2235
P407
P577
2014-12-17T00:00:00Z